Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100477
Status:
COMPLETED
Last Update Posted:
2013-09-25
First Post:
2004-12-30
Brief Title:
Use of Topotecan in Patients With Refractory Acute Leukemia
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Organization Data
Organization:
VA Office of Research and Development
Class:
FED
Study ID:
CADE-RCD1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
US Department of Veterans Affairs
Lead Sponsor Class:
FED
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Immunex Corporation | INDUSTRY |
| SmithKline Beecham | INDUSTRY |
| Amgen | INDUSTRY |